NCT07562308
Laryngeal Mask Airways Are Supraglottic Devices Used to Maintain Airway Patency During Anesthesia and in Difficult Airways. IV Dexmedetomidine Improves LMA Insertion Success and Decreases Coughing, While IV Lidocaine Decreases Postoperative Cough.
Sponsored by Assiut University
Laryngeal Mask Airways Are Supraglottic Devices Used to Maintain Airway Patency During Anesthesia and in Difficult Airways. LMA may help in reducing postoperative pulmonary complications. IV Dexmedetomidine Improves LMA Insertion Success and Decreases trials number, While IV Lidocaine Decreases Postoperative Cough. This is a randomized interventional trial comparing both drugs. IV DEX will be compared vs IV lidocaine regarding the feasibility of insertion, number of trials, incidence of cough, postoperative pulmonary complications and hemodynamic profile.
Inclusion Criteria: * Parental/guardian consent. * Age 2-12 years * ASA physical status I-II. * Elective surgery requiring LMA (duration \<2 hours). Exclusion Criteria: * Known airway anomalies (e.g., tonsillar hypertrophy, cleft palate). * Cardiovascular disease (bradycardia, arrhythmias). * Allergy to study drugs. * BMI \>95th percentile.
Faculty of Medicine Assiut University
Asyut, Asyut Governorate, Egypt
Identity-resolution confidence concerns registry/entity resolution and does not determine clinical eligibility.
Interested in this trial?
Express your interest and we'll connect you with the trial team.
Your selected profile and contact information may be shared with an authorised trial site, sponsor, or Clintriva coordination team for trial contact and pre-screening. Expressing interest does not mean you are eligible or enrolled.
Conditions